https://www.selleckchem.com/pr....oducts/zasocitinib.h
Building an evidence base for CVD prevention in this population will require the engagement of young adults, who are often disconnected from the healthcare system and may not prioritize long-term health. These changes demand a repositioning of existing evidence-based treatments to accommodate new sociotechnical contexts. In this article, the authors review the recent literature and current research opportunities to advance the cardiovascular health of today's young adults.Micro and nanoscale changes allow the optimization of physico
כמו
תגובה
לַחֲלוֹק
